Enlivex (@Enlivex) / X

Enlivex

159 posts

Enlivex

@Enlivex

Developing Allocetra™ for knee osteoarthritis | Prediction markets treasury via @Rain__Protocol | $ENLV

Israel

Joined January 2026

Pinned
Enlivex
@Enlivex
May 29
Enlivex holds 79,568,550,005 RAIN tokens, currently valued at approximately $1.16 billion. According to the Rain Foundation, @Rain__Protocol has surpassed 29,000 users and burned more than 100 million RAIN tokens through its buyback-and-burn mechanism, as of April 27, 2026.
52K
Enlivex
@Enlivex
18h
The largest IPO in market history was tokenized. SpaceX was listed on Nasdaq at a valuation near $1.75 trillion, and on the same day, tokenized shares were made available on @OndoFinance Global Markets. Enlivex has been on this platform since April. Through ENLVon, investors
00:00
110
Enlivex
@Enlivex
Jun 17
Predict any possible outcome. That is what prediction markets look like when the infrastructure is open to everyone. Built on the @Rain__Protocol.
Rain Trade
@rain__trade
Jun 8
Get ready...
00:00
202
Enlivex
@Enlivex
Jun 16
From $1.2 billion to more than $25 billion per month in a single year. The growth of prediction markets is not only in trading activity. As more capital flows in, the data becomes a stronger signal for risk models, macro analysis, and financial decision-making. The sector is
162
Enlivex
@Enlivex
Jun 16
Source:
The Data Shift Transforming Global Finance
From forbes.com
70
Enlivex
@Enlivex
Jun 15
Our quality longevity mission continues to expand its footprint worldwide. Allocetra patent protection now extends to Australia, covering the use of our cell therapy in patients with osteoarthritis through at least 2040. This adds to the intellectual property secured across
231
Enlivex
@Enlivex
Jun 15
Link to full press release:
investors.enlivex.com
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with...
Nes-Ziona, Israel, June 15, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV) (“Enlivex” or the “Company”), a quality longevity company […]
64
Enlivex
@Enlivex
Jun 12
Quality longevity depends on something most people take for granted: the ability to move. More than 22 million Americans are aging alone, with no spouse, no partner, and no nearby family. For this growing demographic, a single chronic condition can collapse the structure of
117
Enlivex
@Enlivex
Jun 12
Sources:
More than 22 million older Americans live alone, are unmarried and don’t have kids. But they’re...
From moneywise.com
73
Enlivex
@Enlivex
Jun 11
People are living longer. But longevity becomes meaningful when quality of life can be preserved. That is the gap between lifespan and healthspan, and why quality longevity is central to the Enlivex mission.
00:00
145
Enlivex reposted
Oren Hershkovitz
@OrenHershkovitz
Jun 10
One of the most unsettling realizations you can have as a scientist is that a field has been asking the wrong question for a hundred years. Osteoarthritis is that field. 🧵
289
Enlivex
@Enlivex
Jun 9
One ticker. Two strategies. Last week in Paris, we hosted a dinner at @proofoftalk. CEO @OrenHershkovitz set out our dual-strategy architecture: Allocetra advancing in the clinic, and a RAIN treasury position in prediction markets infrastructure. Thank you to everyone who
00:00
2K
Enlivex
@Enlivex
Jun 8
Proof of Talk 2026, it has been a privilege. The depth of the conversations, the quality of the connections, and the caliber of people in the room made this one worth every minute. See you next year. @proofoftalk
625
Enlivex reposted
Oren Hershkovitz
@OrenHershkovitz
Jun 4
Thank you to everyone who joined for the Enlivex dinner at @proofoftalk in Paris on Tuesday night. Evenings like that come down to the people and the questions they bring, and this room brought plenty of both. Real conversation about where a clinical-stage company and a
185
Enlivex
@Enlivex
Jun 5
We are initiating a Phase 2b trial in 182 patients across the United States, Denmark, and Poland. This is an important milestone in our quality longevity mission, building on prior clinical data showing meaningful improvements in both pain and knee function for age-related
00:00
132
Enlivex
@Enlivex
Jun 4
Allocetra produced a clinically meaningful, statistically significant improvement over placebo in both pain and function at 6 months in patients with age-related knee osteoarthritis. These results are being presented from the podium at EULAR 2026 in London this week. EULAR
246
Enlivex
@Enlivex
Jun 4
Link to full press release:
investors.enlivex.com
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation...
The data were selected for an oral podium presentation at EULAR and will be presented by Prof. Philip Conaghan, a […]
136